Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain mechanisms and fatigue in rheumatoid arthritis before and after Remicade
2008-005212-40Phase 4Active
- Sponsor
- Karolinska Institutet
- Start
- Aug 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of infliximab in rheumatoid arthritis (RA) (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Central pain mechanisms, Peripheral pain and 3 more. Started Aug 2008; status: active.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-005212-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005212-40.